Graphical Abstract Highlights d Viral infection or its mimic induce large, persistent assemblies of mutant FUS d These assemblies sequester optineurin and nucleocytoplasmic transport factors d Mutant FUS-expressing cells are hypersensitive to virusinduced toxicity d Type I interferon induced by viral infections promotes accumulation of FUS protein SUMMARY Mutations in the FUS gene cause familial amyotrophic lateral sclerosis (ALS-FUS). In ALS-FUS, FUSpositive inclusions are detected in the cytoplasm of neurons and glia, a condition known as FUS proteinopathy. Mutant FUS incorporates into stress granules (SGs) and can spontaneously form cytoplasmic RNA granules in cultured cells. However, it is unclear what can trigger the persistence of mutant FUS assemblies and lead to inclusion formation. Using CRISPR/Cas9 cell lines and patient fibroblasts, we find that the viral mimic dsRNA poly(I:C) or a SG-inducing virus causes the sustained presence of mutant FUS assemblies. These assemblies sequester the autophagy receptor optineurin and nucleocytoplasmic transport factors. Furthermore, an integral component of the antiviral immune response, type I interferon, promotes FUS protein accumulation by increasing FUS mRNA stability.
In Brief
Amyotrophic lateral sclerosis caused by mutations in the FUS gene is characterized by cytoplasmic FUS pathology (FUS proteinopathy). Shelkovnikova et al. find that the antiviral immune response promotes FUS protein accumulation and its coalescence into persistent cytoplasmic assemblies. Viral infection can serve as a trigger of FUS proteinopathy in ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. It is characterized by selective loss of upper and lower motor neurons in the central nervous system (CNS), which causes weakness and paralysis of the skeletal muscles they control (Peters et al., 2015) . Although most cases are sporadic ALS (sALS), $10% of cases bear a familial ALS (fALS) component. Mutations in more than 25 genes have been proven to cause the disease, with the FUS gene being one of the major fALS-causative genes (Kwiatkowski et al., 2009; Vance et al., 2009) .
FUS encodes a predominantly nuclear DNA/RNA binding protein with multiple functions in RNA metabolism (Ratti and Buratti, 2016) . Most ALS-causative mutations affect the nuclear localization signal (NLS) of FUS on its C terminus, thereby disrupting nuclear import of the protein and causing its cytoplasmic overabundance (Bosco et al., 2010; Dormann et al., 2010) . Patients with ALS caused by FUS mutations (ALS-FUS) present with cytoplasmic FUS-positive inclusions in neurons and glia (Deng et al., 2014) . Inclusions formed by non-mutated FUS protein are also found in the brain of some frontotemporal lobar degeneration (FTLD) patients (atypical FTLD-U subtype) (Neumann et al., 2009) . Thus, conditions characterized by the presence of abnormal FUS inclusions are collectively called FUS proteinopathies.
Although FUS readily aggregates in the test tube, this is not the case in vivo, and available rodent models expressing mutant FUS do not develop FUS aggregates in the CNS (Devoy et al., 2017; Huang et al., 2011; Ló pez-Erauskin et al., 2018; Scekic-Zahirovic et al., 2016; Sharma et al., 2016) . Our studies showed that to achieve efficient FUS aggregation in the murine nervous system, highly aggregate-prone artificial variants of FUS lacking RNA binding domains have to be used (Robinson et al., 2015; Shelkovnikova et al., 2013a ). Yet in FUS proteinopathies, fulllength FUS or FUS with small C-terminal truncations forms cytoplasmic inclusions. This implies the requirement of an additional trigger that causes robust FUS aggregation and inclusion formation in human disease. Mutant FUS is characterized by a strong affinity to stress granules (SGs), a type of cytoplasmic stressinduced ribonucleoprotein (RNP) assembly (Bosco et al., 2010; Dormann et al., 2010) . SGs have been heavily implicated in ALS pathogenesis, because ALS-causative mutations affect not only FUS but also several other SG proteins (Li et al., 2013) . In addition to being recruited to stress-induced SGs, overexpressed mutant FUS can spontaneously form small cytoplasmic granules that coalesce into larger assemblies containing SG markers (Kino et al., 2011; Shelkovnikova et al., 2014a) . It has been proposed that FUS-enriched cytoplasmic assemblies, when they persist, may serve as precursors of pathological FUS inclusions in FUS proteinopathies (Bentmann et al., 2013; Shelkovnikova et al., 2013b) . Conspicuously, FUS-positive inclusions in ALS-FUS contain SG marker proteins (Dormann et al., 2010) . However, the nature of a stressor (or stressors) that can induce sustained presence of FUS-positive assemblies and thereby act as a trigger, or second hit, in FUS proteinopathies remains experimentally unaddressed.
Epidemiological and clinical evidence for a connection between viral infection and ALS has been accumulating for decades (Celeste and Miller, 2018; Ravits, 2005; Vandenberghe et al., 2010) . For example, it is known that individuals with a history of poliomyelitis have a higher risk of developing motor neuron disease later in life (Martyn et al., 1988) . Similarly, patients infected with HIV or human T cell leukemia virus 1 develop neurological disorders resembling clinical features of ALS (Alfahad and Nath, 2013) . Importantly, multiple viruses are able to induce SG assembly (McCormick and Khaperskyy, 2017; White and Lloyd, 2012) .
In the current study, we show that the exposure to foreign double-stranded RNA (dsRNA), typical for some viral infections, is a potent inducer of persistent FUS-enriched assemblies in the cytoplasm of cells expressing either exogenous or endogenous mutant FUS. Furthermore, we show that type I interferon (IFN), the central component of antiviral signaling, promotes accumulation of FUS protein. We propose that the antiviral immune response, with its profound effect on FUS levels and distribution, can serve as a trigger of FUS proteinopathy in ALS-FUS.
RESULTS

Viral dsRNA Mimic Causes Formation of Persistent SGs that Recruit Mutant FUS
Our initial aim was to identify stressors that can induce the prolonged presence of SGs in normal (wild-type [WT]) human neuroblastoma (SH-SY5Y) cells. In our analysis, we included neurodegeneration-relevant stressors: sodium arsenite (SA, oxidative stress), dithiothreitol (DTT, endoplasmic reticulum [ER] stress), and MG132 (proteasome inhibition). In addition, we tested a combination of the heat shock protein (HSP) 70 inhibitor pifithrin-m and puromycin that is known to induce SG formation by simultaneous polysome dissociation and accumulation of misfolded proteins (Bounedjah et al., 2014) . Viral infection can be a potent SG inducer; therefore, a viral dsRNA mimic, synthetic dsRNA polyinosinic:polycytidylic acid (poly(I:C)), was included. It is proposed that repetitive stresses causing multiple cycles of SG assembly-disassembly might lead to the appearance of persistent SGs (Wolozin, 2012) . Stress induced by SA, DTT, and MG132 is reversible, which allowed examination of the effect of repetitive stresses. The treatment timeline for each stressor is schematically depicted in Figure 1A . SGs were visualized by staining for the core SG protein G3BP1. SA, DTT, MG132, a combination of pifithrin-m and puromycin, and poly(I:C) induced SG assembly in 100%, 95.3% ± 1.8%, 34.7% ± 2.3%, 30.0% ± 3.6%, and 52.4% ± 3.0% of cells, respectively ( Figure 1B) . Two consecutive stresses with SA, DTT, and MG132, separated by a 24 h recovery period, did not increase SG numbers, and the removal of the stressor after the first and second rounds of stress led to SG disassembly with equal efficiency ( Figure 1B) . The viral infection mimic was the only stressor whose single application induced the assembly of persistent SGs: 24 and 48 h after poly(I:C) transfection, SGs were still detectable in 47.6% ± 3.5% and 27.7% ± 4.0% of cells, respectively ( Figure 1B) . Interestingly, we found that poly(I:C) was also able to induce SGs in a fraction of human embryonic stem cell (hESC)-derived motor neurons ( Figure S1 ). Given the epidemiological link between viral infection and ALS and the ability of multiple viruses to interact with the SG pathway, we focused on this stressor.
Several stressors are known to cause the formation of FUSpositive SGs in cells expressing mutant versions of the protein, including oxidative stress, heat shock, osmotic stress, and proteasome inhibition (Dormann et al., 2010; Mateju et al., 2017; Sama et al., 2013; Shelkovnikova et al., 2014a) ; however, the effect of viral infection on mutant FUS has not been reported. Synthetic dsRNA poly(I:C) is capable of triggering core features of the antiviral response upon its delivery into mammalian cells, including SG formation (Weissbach and Scadden, 2012) . The use of poly(I:C) can mimic a response typical for multiple types and classes of viruses. In our experiments, we used an experimentally defined optimal concentration of poly(I:C) that efficiently and consistently induced SGs in SH-SY5Y cells without overt toxicity ( Figure S2A ).
We studied mutant FUS recruitment into poly(I:C)-induced SGs in recently generated CRISPR/Cas9 cell lines expressing endogenous FUS lacking NLS (FUSDNLS) (An et al., 2019) (see STAR Methods). Homozygous FUSDNLS (DNLS_ho) lines and heterozygous FUSDNLS (DNLS_het) lines are characterized by significant and mild cytoplasmic FUS mislocalization, respectively, and endogenous mutant FUS is efficiently recruited into SA-induced SGs . We found that diffusely distributed cytoplasmic mutant FUS, but not WT FUS, was readily recruited into poly(I:C)-induced SGs visualized with antibodies against SG marker proteins G3BP1, ATXN2, and YBX1 (Figure 2A; Figure S3A ). Poly(I:C)-induced SGs in FUSDNLS lines were bona fide SGs, because they contained polyadenylated RNA ( Figure S3B ) and were sensitive to cycloheximide ( Figure S3C ).
In DNLS_het cells, significantly more SGs assembled early after poly(I:C) transfection (2 and 4 h time points), and more SGs were still present 24 h post-transfection compared with WT cells ( Figure 2B ). In contrast, there was no difference in SG numbers between WT and DNLS_het cells during recovery from SAinduced stress ( Figure 2B ).
We found that upon poly(I:C) stimulation, neuroblastoma cells usually develop larger, few-per-cell SGs, as opposed to multiple small or medium-sized SGs in cells treated with the other stressors tested. We quantified the proportion of cells that possess 1, 2, or >2 SGs per cell and measured the SG area in FUSDNLS cells subjected to SA for 1.5 h or poly(I:C) for 6 h (these stress durations did not significantly affect the morphology or viability of neuroblastoma cells; Figure S2C ). This analysis revealed that a substantial proportion of poly(I:C)-stimulated FUSDNLS cells contained 1-2 SGs per cell, of larger size, compared with SA-stressed cells, which presented with smaller, more numerous SGs ( Figures 2C-2E ). Large SGs induced by poly(I:C) were able to sequester almost the entire pool of FUS in DNLS_ho lines, leading to its nearcomplete nuclear depletion ( Figure 2F ). Finally, poly(I:C) was able to induce FUS-positive SGs in human patient fibroblasts bearing FUS P525L mutation, which were detectable up to 24 h post-transfection ( Figure 2G ).
Thus, mimicking viral infection by dsRNA delivery can cause the prolonged presence of large FUS-positive SGs in cells expressing endogenous mutant FUS.
Mimicking Viral Infection Promotes Formation of Cytoplasmic FUS aggregates
Previously, we and others showed that exogenously expressed mutant FUS forms spontaneous cytoplasmic granules in a fraction of unstressed cells, which we called the experiments to study SG persistence in SH-SY5Y cells. Time points for treatments or transfection, wash-off, and cell collection are indicated by red, blue, and pink arrowheads, respectively. (B) Representative images and quantification of SG-containing cells after stress and recovery. The percentage of SG-positive cells at each time point is indicated on the scatterplots. The x axis labeling (1-4) corresponds to the column labeling (1 st stress, 1 st recovery, 2 nd stress, and 2 nd recovery). SGs were visualized using anti-G3BP1 staining. Between 250 and 300 cells were analyzed per time point for each stressor. N/A, not available; single application of poly(I:C) was used. Data are represented as mean ± SEM; mean percentages of cells with SGs are also indicated on the scatterplots. Scale bar, 10 mm.
FUS granules (FGs) (Kino et al., 2011; Shelkovnikova et al., 2014a) . Consistently, in some FUSDNLS lines, the endogenous level of mutant FUS was sufficient to support the assembly of FGs (lines DNLS2_het and DNLS11_het; Figure 3A ). Similar to FGs formed by overexpressed (exogenous) protein (exoFGs), FGs composed of endogenous protein (endoFGs) were negative for core SG proteins G3BP1 and TIAR ( Figure 3B ) and were sensitive to actinomycin D treatment ( Figure S4 ).
In SA-stressed cells, exoFGs can coalesce into larger assemblies, called FUS aggregates (FAs), which recruit SG proteins (Shelkovnikova et al., 2014a) . We found that poly(I:C) was also capable of triggering the formation of FAs in cells with endoFGs (endoFAs) ( Figure 3C ). These endoFAs were readily distinguishable from FUS-positive SGs because of their grainy, irregularly shaped appearance compared with the amorphous, smooth-edged SGs formed in endoFG-negative FUSDNLS lines (Figure 3C) . endoFAs were able to sequester G3BP1 and TIAR proteins; however, in contrast to FUS-positive SGs, the G3BP1/TIAR signal was intermingled with the FUS signal, forming a patchy pattern within these structures ( Figure 3C ). Similar to FUS-containing SGs, endoFAs persisted in FUSDNLS lines and were still detectable in 45.6% ± 2.1% of cells 24 h posttransfection ( Figure 3D ).
To characterize the dynamics of poly(I:C)-induced FA assembly, we used confocal live imaging of cells with exoFGs formed by GFP-tagged FUS bearing a R522G mutation. Poly(I:C) induced rapid assembly of exoFAs, which grew by clustering, eventually forming one or two large aggregates per cell, and such cells remained alive for at least 12 h ( Figure 3E ; Video S1).
To summarize, our data suggest that the presence of endogenous mutant FUS in the cytoplasm is sufficient to form spontaneous FGs, which can become seeds for larger assemblies, the FAs. Mimicking viral infection promotes the formation of FAs composed of such FGs, which can persist in cultured cells for hours and even days. (D) , and the fraction of cells containing 1, 2, and >2 SGs (E) in FUSDNLS cells are shown. In (D) and (E), data for two DNLS_het and two DNLS_ho lines were combined. Between 250 and 400 cells were analyzed in (D) , and between 92 and 141 cells were analyzed in (E). ****p < 0.0001 (Student's t test). (F) Near-complete clearance of mutant FUS from the nucleus in poly(I:C)-stimulated, but not SA-treated, DNLS_ho cells. Nuclei are circled. Note the loss of nuclear FUS in two SG-containing cells in the poly(I:C)-stimulated culture (nuclei circled in blue). (E) Formation of exoFAs in response to poly(I:C). WT cells were transfected with a FUS R522G GFP expression vector; 24 h later, cells were transfected with poly(I:C); and two cells with preformed exoFGs were followed up for 12 h using time-lapse confocal imaging. Two aggregates that eventually fuse to form one large aggregate are indicated with arrowheads. Also see Video S1. In (A)-(C), representative confocal images (single optical section) are shown. Scale bars, 10 mm.
Poly(I:C)-Induced Mutant FUS Assemblies Sequester Nucleocytoplasmic Transport Factors and the Autophagy Receptor Optineurin
Aggregates composed of mutant FUS have been found to sequester other proteins, such as survival motor neuron (SMN) complex factors, processing body (P-body), and paraspeckle components, presumably leading to their loss of function (Groen et al., 2013; Shelkovnikova et al., 2014a Shelkovnikova et al., , 2014b . Optineurin is the autophagy receptor involved in aggrephagy and encoded by an ALS-linked gene, OPTN; it regulates critical processes at the crossroads of autophagy and viral infection (Ryan and Tumbarello, 2018) . Previously, optineurin was identified as a component of FUS inclusions in ALS-FUS post-mortem tissue (Ito et al., 2011) ; however, its possible recruitment into mutant FUS assemblies in cell models has not been studied. We examined optineurin distribution in SA-and poly(I:C)-stressed WT neuroblastoma cells and found that this protein was sequestered into both types of SGs ( Figure 4A ; Figure S5A ). Focusing on poly(I:C)-induced SGs, we found that in FUSDNLS lines, SGs recruited significantly more optineurin compared with WT cells ( Figure 4B ). Optineurin was also detected in exoFAs formed under basal conditions ( Figure 4C ). In contrast, another ALS-linked protein and important optineurin interactor, TBK1 (Freischmidt et al., 2015; Wild et al., 2011) , was not recruited into FUS-containing SGs or into FAs ( Figure S5B) . Similarly, the principal component of autophagy-initiating complexes, ULK1, was not detected in SGs ( Figure S5B ). Thus, abnormal optineurin retention in FUS assemblies would sequester it from autophagic complexes, which may negatively affect macroautophagy.
Disrupted nucleocytoplasmic transport has been implicated in multiple ALS subtypes (Boeynaems et al., 2016) , whereas SGs have been reported to sequester nucleocytoplasmic transport factors, including Transportin 1 (TNPO1), the main import receptor for FUS . We examined whether poly(I:C)induced mutant FUS assemblies in FUSDNLS cells contain the nucleocytoplasmic transport factors TNPO1, karyopherin alpha 2 (KPNA2), and nucleoporins Nup98 and Nup107 (localized in the inner ring and outer ring of the nuclear pore complex [NPC], respectively). We found that TNPO1, KPNA2, and Nup107, but not Nup98, accumulated within poly(I:C)-induced SGs and endoFAs ( Figure 4D ; Figure S5C ).
These data indicate that dsRNA-induced mutant FUS assemblies can cause partial depletion of optineurin and nucleocytoplasmic transport factors.
Mutant FUS-Expressing Cells Are Hypersensitive to dsRNA Toxicity
We next asked whether the presence of mutant FUS may result in increased sensitivity to dsRNA toxicity. The number of apoptotic cells, as visualized by staining for cleaved caspase-3 (CC3), was significantly increased in DNLS_ho lines compared with WT cells stimulated with poly(I:C) for 24 h ( Figure 5A ). FUS-DNLS lines also had elevated mRNA levels for the pro-apoptotic factor CHOP ( Figure 5B ). Furthermore, human patient fibroblasts bearing FUS P525L mutation had dramatically increased susceptibility to poly(I:C)-induced cell death ( Figure 5C ). Differences in survival between control and patient fibroblasts were already apparent 4 h after poly(I:C) transfection, and quantification of CC3-positive cells revealed that significantly more cells were undergoing apoptosis in mutant fibroblast cultures 8 h post-transfection ( Figure 5C ).
We concluded that cells expressing mutant FUS are less competent at handling dsRNA-induced toxicity than WT cells.
Type I Interferon Stimulates Accumulation of Normal and Mutant FUS Protein
In FUS proteinopathy, FUS protein accumulates in the cytoplasm in large quantities, and its increased local concentration likely contributes to its aggregation and inclusion formation. Because FUS was previously identified as a potent negative regulator of antiviral gene expression (Amit et al., 2009), we hypothesized that during antiviral response, cells may develop increased demand for FUS protein, leading to its upregulation that may contribute to FUS proteinopathy development. In line with this prediction, qPCR analysis revealed upregulation of FUS mRNA in poly(I:C)-stimulated WT cells ( Figure 6A ). Type I IFNs are the principal drivers of gene expression changes in response to dsRNA. Thus, we examined whether FUS mRNA upregulation is downstream of IFN signaling. Treatment with IFNbeta, the main type I IFN induced by poly(I:C) in SH-SY5Y cells (Shelkovnikova et al., 2018) , increased FUS mRNA levels, with a peak at 4 h followed by a gradual decline ( Figure 6B) . The in-crease in FUS mRNA levels was more pronounced in IFN-treated cultures compared with poly(I:C)-stimulated cultures, consistent with induction of IFN response only in a fraction of cells in poly(I:C)-stimulated cultures because of less than 100% transfection efficiency. Consistent with increased mRNA levels, we detected time-dependent accumulation of FUS protein in IFNtreated cells ( Figure 6C ). FUS protein did not accumulate in poly(I:C)-treated cells despite upregulated mRNA ( Figure S6A ). This is explained by significant impairment of protein translation in poly(I:C)-transfected cells, but not in IFN-stimulated cells, as confirmed by puromycin incorporation assay ( Figure S6B ).
FUS mRNA can be upregulated in IFN-treated cells via a transcriptional mechanism or because of its increased stability. We found that FUS pre-mRNA levels in treated cultures did not increase ( Figure 6D ). Furthermore, FUS mRNA upregulation induced by IFN-beta was still evident in cells upon blocking transcription with actinomycin D or dichlorobenzimidazole riboside 5,6-Dichlorobenzimidazole 1-b-D-ribofuranoside (DRB) ( Figure S6C ). STAT1 is the main transcriptional mediator of IFN-beta signaling, and although the FUS gene possesses a STAT1 binding site in its promoter region, the degree of IFNinduced FUS mRNA upregulation was not prevented by STAT1 knockdown ( Figure S6D ). Thus, a transcriptional mechanism may not significantly contribute to the effect of IFN-beta on FUS mRNA levels. Because mRNA stability is mainly regulated by polyadenylation, we measured poly(A) (PA) tail length of FUS mRNA by a PCR-based PAT assay. We found that IFNbeta exposure shifted the intensity of the FUS mRNA smear toward longer PA tails ( Figure 6E ).
We next examined whether IFN-beta exerted a similar effect on mutant FUS. We found that FUS protein levels increased after 24-h IFN-beta treatment not only in WT cells but also in (E) FUS mRNA species with longer PATs accumulate in cells treated with IFN-beta as revealed by the PAT assay. The diagram shows the principle of the PAT assay. P1, P2, and P3 are FUS-specific forward, FUS-specific reverse, and universal reverse primers, respectively. PA stands for poly(A) tail (amplified with P1 and P3), and int stands for the internal FUS fragment (amplified with P1 and P2). The electrophoresis image demonstrates a similar band intensity for the internal (legend continued on next page) FUSDNLS lines ( Figure 6F ). Strikingly, both normal and mutant FUS proteins continued to accumulate 24 h after removing IFN-beta from the culture medium ( Figure S6E ). At the same time, in IFN-beta-treated cells, subcellular localization of FUS remained unaffected ( Figure 6G ). IFN treatment alone did not induce SGs in mutant FUS-expressing cells, consistent with previous findings (John and Samuel, 2014) and with a limited effect of IFN on protein translation ( Figure S6B ). FUS mRNA levels are known to be subject to autoregulation, in which FUS protein binds its own transcript and promotes production of an unstable isoform lacking exon 7; autoregulation ability of mutant FUS is impaired . Consistent with defective autoregulation of FUS mutants, FUSDNLS cells failed to upregulate the exon 7-skipped (ex7À) FUS isoform during IFN treatment ( Figure 6H ).
Overall, our data indicate that type I IFN, the main component of antiviral signaling, can drive accumulation of mutant FUS protein.
Infection with an RNA Virus Induces FUS Pathology in Mutant FUS-Expressing Cells
To corroborate the data obtained with a viral infection mimic, we next investigated changes in mutant FUS distribution in response to an RNA virus infection. Respiratory syncytial virus (RSV) possesses a negative-sense RNA genome, which gives rise to a dsRNA intermediate in its life cycle; it is capable of maintaining a prolonged stress response accompanied by SG assembly (Groskreutz et al., 2010; Lindquist et al., 2010) . Inoculation of WT SH-SY5Y cells with RSV strain A2 led to the appearance of cell clusters with altered cellular morphology, including nuclear swelling and the presence of SGs, 24 h post-infection ( Figure 7A ). Infected cultures also displayed upregulation of viral infection markers IFN-beta, IFIT3, and CXCL10 ( Figure 7B ). We next inoculated WT and FUSDNLS lines and analyzed them 8, 24, and 48 h post-infection. Similar to poly(I:C)-stimulated cells, FG-negative FUSDNLS lines developed large FUS-positive SGs, whereas a FG-positive line (DNLS11_het) developed endoFAs 24 h post-infection (Figure 7C) . At this time point, the proportion of SG-positive cells was higher in FUSDNLS cultures compared with WT cells (Figure 7D) . Prolonged RSV infection was toxic for neuroblastoma cells, leading to significant cell death 48 h post-infection, which was more pronounced in FUSDNLS lines ( Figure 7E ). FUS-positive SGs were still detectable in some cells at this stage (Figure 7E, insets) . RSV infection was also capable of inducing FUS-positive SGs in FUS P525L human patient fibroblasts (Figure 7F ). Consistent with poly(I:C) and IFN data ( Figure 6 ), infected WT and FUSDNLS cells both presented with FUS mRNA upregulation ( Figure 7G ). Finally, RSV-induced mutant FUS assemblies sequestered optineurin, TNPO1, and Nup107 ( Figure 7H ).
Overall, core features of FUS pathology triggered by a synthetic dsRNA were observed after infection with a SG-inducing virus.
DISCUSSION
In FUS proteinopathies, cytoplasmic accumulation of FUS can be dramatic, leading to the formation of large inclusions sometimes filling the entire cytosolic space (Deng et al., 2010) . Yet even overexpression of ALS-linked FUS mutants in the mammalian CNS is not sufficient to cause overt FUS deposition and proteinopathy. Based on our data, we propose a model whereby a viral infection involving dsRNA response can serve as a trigger, or second hit, for FUS proteinopathy in humans. It does so by causing (cytoplasmic) FUS accumulation, formation of persistent FUS-enriched cytoplasmic assemblies, and impaired aggrephagy. The nature of the third hit, which would facilitate the conversion of dynamic FUS-positive assemblies into stable proteinaceous inclusions, remains unclear. However, one can speculate that viral manipulation of the host RNA levels may be a contributory factor. Viral infections are often associated with attenuated host gene transcription and RNase L-mediated cleavage of cellular RNAs (Abernathy and Glaunsinger, 2015) , whereas we and others showed that RNA binding protects FUS from irreversible aggregation (Maharana et al., 2018; Shelkovnikova et al., 2014a) . The existence of an additional factor or factors triggering FUS proteinopathy is consistent with the recently proposed multistep model for ALS development, in which intrinsic and extrinsic risk factors interact to realize the genetic predisposition and initiate the pathological process (Al-Chalabi et al., 2014) . Considering that ALS is a six-step process and that mutations decrease the number of steps, two or three steps will still be necessary for the development of the disease (Chiò et al., 2018) .
Several stresses, including those implicated in neurodegeneration, such as proteasomal dysfunction, oxidative stress, and ER stress, are known to cause formation of FUS-positive assemblies in cultured cells, including neurons (Ederle and Dormann, 2017) . However, such assemblies are unstable and readily dissipate when stress is resolved. Moreover, all of these stressors cause an acute response that, if not resolved after a short period (usually up to several hours), kills the cell. In most instances, SGs eventually disassemble to allow restoration of translation, even if the stress persists (Shelkovnikova et al., 2017) . SG-inducing viral infections are principally different in this regard, because they result in prolonged and, in some cases, oscillating SG response, which allows phases of active and stalled translation and FUS fragment but increased intensity of the smear corresponding to the longer PA tails; the intensity profile of the PA tail lanes is also shown. Cells were treated with IFN-beta for 8 h. (F) Mutant FUS protein accumulates in FUSDNLS cells upon IFN-beta treatment. Cells were treated with IFN-beta for 24 h. The FUS knockout line was included as a negative control. (G) IFN-beta treatment does not alter the subcellular localization of normal and mutant FUS. Cells were treated with IFN-beta for 24 h. Scale bar, 10 mm. (H) Levels of FUS ex7À mRNA transcript significantly increase in WT lines, but not in FUSDNLS lines, upon IFN-beta exposure. Cells were treated with IFN-beta for 24 h and analyzed by qRT-PCR. n = 4, *p < 0.05 (Mann-Whitney U test). In all panels, data are represented as mean ± SEM. ensures cell survival (Ruggieri et al., 2012) . Thus, antiviral response may initiate and/or promote FUS proteinopathy in neurons and glia while keeping these cells alive for a period long enough to allow FUS inclusion formation.
Here, we refer to FAs composed of spontaneous FGs and FUS-positive SGs in cultured cells as mutant FUS-containing cytoplasmic assemblies. The ability of mutant FUS to assemble into FGs under basal conditions and subsequently into FAs under conditions of stress in cultured cells, including neurons, has been confirmed by us, as well as by several other groups (Japtok et al., 2015; Kino et al., 2011; Lenzi et al., 2015; Shelkovnikova et al., 2014a) . Regardless of the relative contribution of FUS-positive SGs and FAs to the disease pathogenesis, in the current study, we have shown that antiviral signaling can promote the formation and persistence of both types of assemblies.
Compromised autophagic clearance has been heavily implicated in the proteinopathy development in different ALS subtypes (Weishaupt et al., 2016) . Previously, mislocalized FUS has been shown to negatively affect autophagic protein clearance, which can contribute to FUS proteinopathy development (Ryu et al., 2014; Soo et al., 2015) . Our findings corroborate the histopathological data (Ito et al., 2011) on possible loss of function of optineurin and hence impairment of aggrephagy in ALS-FUS. Autophagy is known to function in the control of viral replication and to exert other antiviral effects; many viruses have evolved mechanisms to inhibit autophagy at different levels (Lee and Iwasaki, 2008) . Therefore, a viral infection could exacerbate pre-existing defects in autophagy in mutant FUS-expressing cells.
Available data suggest that even subtle changes in FUS levels can trigger motor neuron pathology. ALS-causative mutations in the FUS 3 0 UTR, which cause increased protein levels, have been In all panels, cells were infected with RSV strain A2 at a multiplicity of infection (MOI) of 10 and analyzed at the indicated time points. In (B), (D) , and (G), data are represented as mean ± SEM. In (A), (C), (E), (F), and (H), representative images are shown. Scale bars, (A) 50 mm; (C), (F), and (H) 10 mm; and (E) 100 mm.
described (Sabatelli et al., 2013) . In the current study, we report the ability of a physiologically relevant molecule, type I IFN, to trigger accumulation of FUS protein. In addition, although IFN per se does not induce SG assembly, it can potentiate SG formation in infected cells (John and Samuel, 2014; Ruggieri et al., 2012) . Type I IFN induction is not limited to viral infection and can be caused by other immune stimuli; however, sustained IFN expression is observed only during antiviral signaling (Amit et al., 2009) . Both neurons and glia express IFNs and their receptors (Chhatbar et al., 2018) . Interestingly, we found that one of the two IFN receptor subunits, IFNAR1, is highly expressed specifically in ventral horn neurons of the spinal cord and that it is depleted from the spinal cord of ALS-FUS patients ( Figure S7 ). Because IFNAR1 undergoes ligand-dependent degradation during viral infection (de Weerd and Nguyen, 2012) , this finding is consistent with the idea that sustained antiviral signaling might take place in the nervous system of ALS-FUS patients.
Viral infections are known to promote formation of another type of RNA granule, paraspeckles (Imamura et al., 2014) , whereas spinal neurons in ALS, including ALS-FUS, are characterized by paraspeckle hyperassembly Nishimoto et al., 2013; Shelkovnikova et al., 2018) . Activation of paraspeckle signaling in the ALS spinal cord provides yet more evidence in support to the hypothesis of activated antiviral response in this disease.
The model proposed here is fully applicable for ALS-FUS, but for FTLD-FUS cases, which usually do not involve FUS mutations, additional factors are required to cause nuclear import defect. However, such a defect might be caused by viral subversion of the NPC. Viruses are known to hijack NPC components and other factors to enable trafficking of viral proteins (Le Sage and Mouland, 2013). Furthermore, some viral proteins have a high affinity to TNPO1. For example, enterovirus and cardiovirus infections alter NPC composition to relocalize some nuclear proteins to the cytoplasm, whereas enteroviruses are known to induce degradation of nucleoporins Nup62, Nup98, and Nup153 (Hindley et al., 2007) . A combination of a viral infection and the presence of persistent FUS assemblies that sequester NPC components can have an additive negative effect on nucleocytoplasmic transport.
In addition to the existence of an epidemiological link between viral infections and ALS (Ravits, 2005; Vandenberghe et al., 2010) , several viruses are known to cause cellular and molecular phenotypes typical for ALS. For example, enteroviral and encephalomyelitis infections result in cytoplasmic aggregation of TDP-43 in vivo in the murine CNS (Masaki et al., 2019; Xue et al., 2018) . Enteroviruses (including poliovirus) possess a dsRNA intermediate in their life cycle that triggers SG formation (Lloyd, 2016) . Incomplete and non-penetrance is common for FUS mutations, with the age of onset varying from early 20 s to late 70 s even within the same family . Thus, one can speculate that common viral infections can trigger the disease, which otherwise would not manifest, by dysregulating cellular pathways already perturbed in individuals genetically predisposed to develop ALS.
In conclusion, our study provides a framework for investigating the role of the antiviral signaling in FUS proteinopathies. Further studies are needed to establish whether viral infection would be sufficient to induce formation of FUS inclusions in mo-tor neurons derived from ALS-FUS patient induced pluripotent stem cells (iPSCs) and, most interestingly, in the available rodent models of FUS pathology.
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Western blotting
Cell were lysed on plates in 2xLaemmli buffer and the lysates were boiled at 100 C for 5 min. Proteins were separated on 10% SDS-PAGE and transferred to PVDF membranes followed by incubation in 4% skimmed milk for 1 h and in primary antibodies (1:1,000) at 4 C overnight. HRP-conjugated secondary antibodies (1:3,000, Amersham) were applied at RT for 1.5 h. ECL solution (Advansta) was used for chemiluminescent detection. Western blots were re-probed for b-actin as a control for equal loading. Protein labeling with puromycin was performed as described earlier (Shelkovnikova et al., 2017) .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was carried out using GraphPad Prism 6 software. Mean values of biological replicates were compared using appropriate tests (stated in the figure legends). Significance levels are indicated with asterisks (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). N indicates the number of biological replicates. Error bars represent standard error of the mean (SEM).
DATA AND CODE AVAILABILITY
This study did not generate any unique datasets or codes. (B) Concentration-dependent toxicity of poly(I:C) in SH-SY5Y cells. Cells were transfected with the corresponding amount of poly(I:C) (per well, in 24-well plates) and analysed 24 h post-transfection using anti-cleaved caspase 3 (CC3) staining (x20 magnification). Note that 250 ng was selected for all subsequent experiments due to the optimal balance between SG induction and cell survival. Data are represented as mean±SEM. *p<0.05, **p<0.01 (Mann-Whitney U test).
(C) Poly(I:C) stimulation for 6 h and SA treatment for 1.5 h do not affect cell morphology and do not induce significant toxicity. SH-SY5Y cells were treated with SA or transfected with poly(I:C) and analysed after 1.5 h or 6 h, respectively, using a combination of anti-TIAR and cleaved caspase 3 (CC3) staining. Lipofectamine2000 (LP2000)-treated cells were included as a control for poly(I:C) transfection. Scale bars, general plane -100 µm, close up -10 µm. (C) Nucleocytoplasmic transport factor Nup98 is not detected in mutant FUS-containing cytoplasmic assemblies in poly(I:C)-stimulated FUSΔNLS cells.
In B and C, cells were analysed 6 h post-transfection; note that ∆NLS11_het cell line contains endoFGs and therefore forms FAs not SGs.
Scale bars, 10 μm. (A) IFNAR1 immunohistochemistry in the spinal cord sections for two control cases and two ALS-FUS cases. Note that control 1 and ALS-FUS 1 were counter-stained with H&E. Scale bars, 50 µm and 10 µm in upper and lower panels, respectively.
(B) Western blot analysis of IFNAR1 levels in the spinal cord of two control and two ALS-FUS patients.
